Molecular Imaging Market Size Worth USD 13.97 Billion by 2034 | CAGR: 4.6%

Molecular Imaging Market Size Worth USD 13.97 Billion by 2034 | CAGR: 4.6%


The molecular imaging market size is expected to reach USD 13.97 billion by 2034, according to a new study by Polaris Market Research. The report “Molecular Imaging Market Size, Share, & Industry Analysis Report: By Modality, By Application, By End Use (Hospitals, Diagnostics Imaging Centers, and Research Institutes), and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular imaging is a medical technique that visualizes and measures biological processes at the molecular and cellular levels within living organisms, enabling early and precise disease diagnosis.

Governments, universities, and private companies are investing more in research and development (R&D) for healthcare technologies. These investments are helping scientists discover new imaging agents and improve existing imaging machines. More funding also speeds up the process of turning research into real-world medical tools. As a result, more advanced and effective molecular imaging products are entering the market. This ongoing support for innovation is essential for developing new ways to diagnose and treat diseases, which increases the demand for molecular imaging solutions across the globe.

Bottom of Form

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/molecular-imaging-market/request-for-sample

In the past, getting new imaging agents and technologies approved for clinical use could take many years. However, regulatory agencies such as the FDA and EMA are now streamlining their processes to help bring safe and effective products to market faster. These improved pathways encourage companies to develop and launch new molecular imaging tools. Faster approvals mean quicker adoption by hospitals and clinics, which helps patients benefit from the latest technologies sooner. This regulatory support is creating a more favorable environment for innovation and growth in the molecular imaging market.

Molecular Imaging Market Report Highlights

  • In 2024, the hospital segment dominated the molecular imaging market due to the availability of high-end equipment and skilled professionals to perform complex tasks.
  • The cardiovascular segment is expected to witness significant growth during the forecast period due to the rising prevalence of cardiovascular disease worldwide.
  • In 2024, North America dominated the market due to its well-established healthcare infrastructure and strong investments in medical technology.
  • Asia Pacific is expected to record the highest CAGR in the forecast period, driven by increasing healthcare awareness, rising investments, and expanding medical infrastructure in countries such as China, Japan, and South Korea.
  • A few global key market players are Bruker; Canon Medical Systems Corporation; Cubresa Inc.; GE HealthCare; Koninklijke Philips N.V.; Mediso Ltd.; Positron; Shimadzu Corporation; Siemens Healthineers AG; and United Imaging Healthcare Co., Ltd.

Polaris Market Research has segmented the molecular imaging market report on the basis of modality, application, end use, and region:

By Modality (Revenue USD Billion, 20202034)

  • Molecular Ultrasound Imaging
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Nuclear Magnetic Resonance (NMR) Spectrometer
  • Others

By Application (Revenue USD Billion, 2020–2034)

  • Cardiovascular
  • Neurology
  • Oncology
  • Respiratory
  • Gastrointestinal

By End Use (Revenue USD Billion, 2020–2034)

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutes

By Regional Outlook (Revenue – USD Billion, 2020–2034)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Argentina
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa
    • Rest of Middle East & Africa